Loading…
Legislative Progress
Introduced
September 12, 2007
Latest Action
September 12, 2007
Primary Sponsor
Debbie StabenowDemocratic(MI)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2009 · first_quarter · Medical/Disease Research/Clinical Labs
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · fourth_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382, the ALS Registry Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
Seek passage of the SMA Treatment Acceleration Act (H.R. 3334 / S. 2042)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2008 · fourth_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · fourth_quarter · Health Issues
H.R. 3334/S. 2042 SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease- H.R. 5265/S. 2618, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008; H.R. 3334/S. 2042, SMA Treatment Acceleration Act; H.R. 493/S. 358 (P.L. 110-233), Genetic Information Nondiscrimination Act; H.R. 2295/S. 1382, the ALS Registry Act.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265/S. 2618, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008; H.R. 3334/S. 2042, SMA Treatment Acceleration Act; H.R. 493/S. 358, Genetic Information Nondiscrimination Act; and H.R. 2295/S. 1382, the ALS Registry Act.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382, the ALS Registry Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Seek passage of the SMA Treatment Acceleration Act (H.R. 3334 / S. 2042)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2008 · third_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · third_quarter · Health Issues
H.R. 3334 / S. 2042 SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · second_quarter · Health Issues
Worked to secure the introduction of, and increase support for, The SMA Treatment Acceleration Act (H.R. 3334 / S. 2042).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2008 · second_quarter · Health Issues
H.R.3334 / S.2042 SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
Worked to secure the introduction of, and increase support for, The SMA Treatment Acceleration Act (H.R. 3334 / S. 2042).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2008 · first_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · first_quarter · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · first_quarter · Health Issues
H.R.3334 / S.2042 SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $30,000
2007 · year_end · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for additional federal resources for Spinal Muscular Atrophy (SMA) research H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2007 · year_end · Medical/Disease Research/Clinical Labs
Raising awareness and advocating for additional federal resources for Spinal Muscular Atrophy (SMA) research H.R. 3334, S. 2042 The SMA Treatment Acceleration Act
Client expense: Not reported · Firm income: $60,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
| Independent |
| VT |
| Dianne Feinstein | Democratic | CA |
| Frank R. Lautenberg | Democratic | NJ |
| Hillary Clinton | Democratic | NY |
| Jack Reed | Democratic | RI |
| Jeff Bingaman | Democratic | NM |
| Jim Webb | Democratic | VA |
| John F. Kerry | Democratic | MA |
| John Warner | Republican | VA |
| Johnny Isakson | Republican | GA |
| Joseph I. Lieberman | Independent | CT |
| Maria Cantwell | Democratic | WA |
| Patty Murray | Democratic | WA |
| Robert Menendez | Democratic | NJ |
| Robert P. Casey, Jr. | Democratic | PA |
| Saxby Chambliss | Republican | GA |
| Sheldon Whitehouse | Democratic | RI |
| Sherrod Brown | Democratic | OH |